VEINOPLUS® V.I. is a medical electro-stimulation device with therapeutic effects upon various symptoms of Venous Insufficiency. These effects have been demonstrated and documented in several clinical studies  made since 2004 in France, UK, USA and Russia DIV>
Over 100 000 people with venous problems in 25 countries have already chosen the technology VEINOPLUS® V.I. STRONG> FONT> DIV> LI> UL>
Le Tohic A., Bastian H., Pujo M., Beslot P., Mollard R., Madelenat A.
GYNECOLOGIE OBSTETRIQUE & FERTILITE 2009
(a) Service de gynécologie-obstétrique, maternité Aline-de-Crépy, hôpital Bichat Claude-Bernard, AP–HP, 46, rue Henri-Huchard, 75018 Paris (b) Cabinet de kinésithérapie, 22, rue des Cascades, 93160 Noisy-Le-Grand (c) EA 4070, laboratoire d’anthropologie appliquée, université Paris Descartes, 45, rue des Saints-Pères, 75270 Paris cedex 06
To assess if electrostimulation of lower limbs relieves lower limbs venous insufficiency-related symptoms during pregnancy.
Patients and methods
A two-step study was conducted. First, a monocentric prospective preliminary study including 30 pregnant women was conducted to assess the effects of electrostimulation on fetal monitoring and uterine contractions. Then, a multicentric prospective non-randomised study including 58 pregnant women with a gestational age between 23 and 33 weeks of amenorrhoea was conducted to evaluate the electrostimulation treatment. This evaluation was based on a clinical examination performed pre- and post-treatment, a CIVIQ questionnaire filled out pre- and post-treatment and a daily diary filled out by the patient during treatment duration. Treatment duration was 21 days including two daily treatment sequences of 20min. Three groups of patients were identified based on initial intensity of venous insufficiency-related symptoms (group 1 minor symptoms, group 2 moderate symptoms, group 3 severe symptoms).
Preliminary study showed no interferences between electrostimulation and fetal cardiac rhythm, uterine contractions and maternal uterine and fetal umbilical arteries Doppler. Concerning the evaluation of the electrostimulation: in group 1, electrostimulation significantly reduced heavy legs sensation (p <0,001) and calves pain (p =0,02) between the beginning and the end of the treatment. The four scores calculated with the CIVIQ questionnaire decreased after treatment and a significant reduction was noted for generalised pain feeling (p =0,04) and psychological impact (p =0,03). In group 2, a significant decrease was noted for tiredness (p <0,001), heavy legs sensation (p <0,001), calves pain (p <0,001) and edema (p =0,02) between the beginning and the end of the treatment. The four scores calculated with the CIVIQ questionnaire significantly decrease after 21 days of treatment. In group 3, a significant decrease of heavy legs sensation (p =0,03) and calves and malleoli perimeters (p <0,05) was noted. After 21 days of treatment, the four scores calculated with the CIVIQ questionnaire significantly decrease (p <0,05). When comparing the three groups, beneficial effects of the treatment are most marked in group 2 regarding subjective symptoms, CIVIQ questionnaire scores and leg pain. According to the patients, effectiveness and tolerance of the treatment ranged from good to excellent in the three groups.
Discussion and conclusion
Electrostimulation is an effective and well-tolerated treatment of lower limbs venous insufficiency-related symptoms in pregnant women. Its use during pregnancy did not show any effects on fetus and pregnancy.